Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Monte Rosa Therapeutics, Inc
Jonsson Comprehensive Cancer Center
Washington University School of Medicine
AstraZeneca
Klus Pharma Inc.
Sarcoma Oncology Research Center, LLC
Cybrexa Therapeutics
Salubris Biotherapeutics Inc
Instituto Oncológico Dr Rosell